Anti-CBR1 Antibody

This unconjugated mouse monoclonal IgG1 antibody from Antibodies.com targets CBR1 (carbonyl reductase 1), an NADPH-dependent oxidoreductase of the short-chain dehydrogenase/reductase superfamily that reduces endogenous and xenobiotic carbonyl substrates, including steroid ketones, prostaglandins, and quinone-containing chemotherapeutics such as doxorubicin.

Validated for Western blot (WB) and immunocytochemistry (ICC) on human samples, it detects the ~30 kDa monomeric enzyme in cytosolic fractions. Researchers studying drug metabolism, oxidative stress responses, and tumor biology rely on this reagent to profile CBR1 expression across cell lines and primary cultures.

Supplied as a 100 µl liquid aliquot in a vial format, the antibody is suited to dilution into standard immunostaining and blotting workflows. Store refrigerated and protect from light to preserve activity through repeated use.